Study guide

1.2 Clinical History, Symptoms, Indications, and Risk Factors

CCI Registered Cardiac Sonographer RCS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: RCS Orientation and Clinical Context

1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context

2 Chapter 2: Orders, Safety, and Patient Preparation

2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare

3 Chapter 3: Reporting and 2-D TTE Foundations

3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA

4 Chapter 4: M-Mode and Doppler Acquisition

4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition

5 Chapter 5: Advanced Doppler and Contrast

5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts

6 Chapter 6: Stress Echocardiography

6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation

7 Chapter 7: TEE, Strain, and 3-D TEE

7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts

8 Chapter 8: 3-D TTE and the Aortic Valve

8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States

9 Chapter 9: Aortic Regurgitation and Mitral Structure

9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability

10 Chapter 10: Mitral and Tricuspid Valve Findings

10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment

11 Chapter 11: Right-Sided Valve Disease

11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment

12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves

12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch

13 Chapter 13: Endocarditis and Cardiac Chambers

13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function

14 Chapter 14: Cardiomyopathy Phenotypes and Diastology

14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls

15 Chapter 15: Systolic Function and Ischemia

15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications

16 Chapter 16: Pericardium and Great Vessels

16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation

17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition

17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues

18 Chapter 18: Devices, Strain, and Hemodynamics

18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts

19 Chapter 19: Infiltrative Disease and Physics Foundations

19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing

20 Chapter 20: Resolution and Doppler Optimization

20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain

21 Chapter 21: 2-D, 3-D, and Contrast Optimization

21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts

1.2 Clinical History, Symptoms, Indications, and Risk Factors

Key Takeaways Explain This Topic AI

A clinical history should identify the indication, question, symptom trajectory, relevant diagnoses and interventions, and current physiologic conditions.

History directs focused attention while the complete adult TTE protocol remains complete unless a properly ordered limited study applies.

Risk factors and medications provide mechanism and loading context but do not by themselves establish an echocardiographic diagnosis.

Unstable symptoms or vital signs require policy-based escalation, and history access remains limited by privacy and minimum-necessary rules.

Last updated: July 2026

History is a protocol-driving dataset

Reviewing clinical history is not a clerical prelude to scanning. It converts a general order into answerable echocardiographic questions. CCI places this task in Performing Non-Imaging Responsibilities, and adult laboratory standards require a process for obtaining and recording the indication and gathering additional information needed to direct the examination. The sonographer does not independently diagnose the patient or replace the ordering clinician. The sonographer verifies identity and order, clarifies the question, acquires the views and measurements needed to answer it, observes safety, and communicates through laboratory policy.

Begin with the order: requested procedure, reason for the study, urgency, and explicit clinical question. Then reconcile it with the patient, chart, and available handoff. A requisition that says only murmur or dyspnea may be technically valid in a local system yet clinically thin. Ask concise, neutral questions: When did the symptom begin? Is it new or worse? What triggers it? What cardiac diagnoses, operations, devices, or recent interventions are known? A patient's description can reveal a prosthetic valve, recent infarction, dialysis session, chemotherapy exposure, or abrupt symptom change that materially focuses acquisition. Document the source when information conflicts rather than silently choosing one version.

Presenting clue Clinical context to clarify Echo attention it may prompt

Dyspnea, orthopnea, edema, weight gain Onset, exertional threshold, heart-failure history, renal disease, diuretic use Ventricular function, filling context, valves, right heart, venous congestion, pericardium

Chest pain or suspected ischemia Timing, exertional relation, ECG or biomarker context, prior infarction or revascularization Regional wall motion, global function, mechanical complications when clinically suspected

Syncope, presyncope, or dizziness Exertional occurrence, rhythm history, murmur, family history, device status Outflow obstruction, valve disease, cardiomyopathy, ventricular function

Murmur New versus known, location if documented, symptoms, valve history Complete valve anatomy, color flow, aligned spectral Doppler, chamber response

Fever, bacteremia, or embolic event Organism and culture timing when available, prosthetic material, injection exposure, neurologic symptoms Valve or device-associated masses and regurgitation; urgent communication if significant findings appear

Pulmonary hypertension concern Lung disease, thromboembolism, sleep apnea, connective-tissue disease, oxygen use Right-heart size and function, tricuspid regurgitant signal, septal behavior, IVC, left-heart contributors

Cardiotoxic therapy surveillance Agent, dose or cycle, treatment dates, baseline study, symptoms Reproducible ventricular volumes, ejection fraction, and strain when ordered and feasible

The last column is a focus, not permission to omit the complete protocol. A complete adult TTE still evaluates cardiac chambers, valves, great vessels, flow, and recognized abnormalities from multiple views unless the order and laboratory policy support a limited examination. History directs extra care; it does not excuse tunnel vision.

Build the pre-scan clinical snapshot

Use a repeatable sequence. First, confirm two patient identifiers and match the order to the intended patient and procedure. Second, identify the primary indication and the question the referring team wants answered. Third, capture symptoms with onset, course, severity, triggers, and associated features. Fourth, review relevant diagnoses, operations, interventions, implanted devices, prior studies, medications, and current support. Fifth, note physiology at the time of imaging: blood pressure, heart rate and rhythm, oxygen requirement, height, weight, body surface area when used, and important timing such as dialysis or medication administration.

Risk factors supply probability and mechanism, but they are not findings. Hypertension may explain remodeling or altered loading; diabetes, dyslipidemia, smoking, established coronary disease, and family history increase ischemic context; obesity and sleep apnea affect image quality and right-heart questions; chronic kidney disease changes volume status; atrial fibrillation changes beat selection; connective-tissue or genetic history may heighten aortic concern. Record relevant facts without assuming that a risk factor proves a disease.

Medications and interventions can change the observed state. A diuretic given before the study may alter congestion. Vasopressors and inotropes affect loading and contractility. Rate control changes cycle length. Anticoagulation supplies context for atrial fibrillation or prosthetic valves but does not rule out thrombus. Recent valve repair or replacement, septal closure, left atrial appendage occlusion, pacemaker or defibrillator placement, ventricular assist support, transplant, ablation, or coronary intervention can modify the protocol and the structures requiring deliberate documentation.

Apply history without overstepping

Consider an inpatient ordered for TTE because of shortness of breath. The chart adds fever, positive blood cultures, a bioprosthetic aortic valve, and new hypotension. That is no longer a generic ventricular-function study. Verify the order and current status, tell the interpreting or supervising team according to policy, document prosthetic valve type and procedure date if available, obtain the complete required dataset with focused valve and regurgitation assessment, and promptly escalate significant observations. Do not tell the patient that endocarditis is present; image, document, and communicate.

Safety can supersede routine workflow. New chest pain, severe respiratory distress, syncope, neurologic change, unstable blood pressure, or a dangerous rhythm requires immediate assessment and escalation under facility policy, not silent completion of the protocol. Explain the examination in understandable language, adapt positioning to the patient's condition, use infection-control precautions, and preserve dignity.

History review also has a privacy boundary. Open only information needed for the examination, discuss it with people involved in care, protect screens and worklists, and avoid public conversations. HIPAA's minimum-necessary principle and local access rules apply even when curiosity might improve background knowledge. A disciplined history review ends with a short internal statement: this patient is having this study now, for this question, under these physiologic conditions, with these safety and protocol implications.

Thirty-second history synthesis

Before placing the transducer, state the indication, symptom trajectory, major cardiac history or intervention, current rhythm and blood pressure, and the one feature that most changes protocol or urgency. If one element is unknown, identify it as unknown rather than inventing it.